Reducing the Acute Care Burden of Childhood Asthma on Health Services in British Columbia

University of British Columbia

Status and phase: Completed; Phase 4

Conditions: Asthma; Upper Respiratory Tract Infection

Treatments: Drug: Arm 1 Oral Cortico Steroids

Study type: Interventional

Funder types: Other

Identifiers

NCT01326494

H10-00184

Details and patient eligibility

About

The purpose of this study is to investigate the benefits of giving filled prescription of a medication to be used upon early onset of symptoms of URTI induced asthma. The hope is to reduce the need to present to Health Care centres for treatment.

Full description

In Canada, asthma affects more the 12% of children. Exacerbation are a common feature of asthma. In children, upper respiratory tract infection (URTI's) are responsible for over 80% of asthma exacerbation.

Experts in asthma care acknowledge this critical problem and have developed guidelines to reduce asthma exacerbation.

The criteria for participation in this study to have 2 or more presentations to a Health Service centre in the past 12 months for URTI induced asthma. These patients will be followed and interviewed monthly over a 12 month period to investigate whether the use of Oral cortico-steroids upon early onset of URTI induced asthma prevents the need for presentation to hospital

Enrollment: 92 patients

Sex: All

Ages: 12 months to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 2 or more presentations to Emergency department in a 12 month period

Exclusion criteria

• less then 2 presentations to Emergency department in a 12 month period

Trial design

Primary purpose: Prevention

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

92 participants in 2 patient groups

Arm 1 Oral Cortico Steroid

Active Comparator group

Description:

A filled prescription will be given to be used upon early onset of symptoms.

Treatment:

Drug: Arm 1 Oral Cortico Steroids

Usual care for Asthma treatment

No Intervention group

Description:

monitor the readmission of URTI induced asthma in children over a 12 month period